Evaluation of vaccine perceptions in Israel's Elderly: A Comparative study of COVID-19 and influenza vaccination attitudes.

Vaccine X

Clinical Microbiology Laboratory, Tzafon Medical Center, Poriya, Israel, affiliated with Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel.

Published: October 2024

Purpose: This study aimed to evaluate the attitudes of Israeli elderly population towards COVID-19 and influenza vaccines, and to assess factors contributing to these attitudes.

Methods: Four-hundred and one participants exhibiting symptoms consistent with COVID-19 or influenza were enrolled and filled out a questionnaire. A second questionnaire was filled out for hospitalized patients at discharge. Nasopharyngeal samples were collected and detected for COVID-19 and influenza presence by reverse transcription PCR. Participants were divided into 3 groups according to their attitude towards vaccine- Pro-vaccine, Anti-vaccine and Dependent group, which represented participants whose stance depended on disease infection rate.

Results: Out of 401 participants, 11.2% (45/401) tested positive for COVID-19, 10.5% (42/401) were positive for Influenza A and one (0.2%) patient had Influenza B. The participants expressed varied beliefs about COVID-19 vaccine: 14.7% (59/401) agreed that it causes disease, 25.4% (102/401) doubted vaccine effectiveness and 22.9% (92/401) questioned vaccine safety. A higher percentage of individuals in Pro-Vaccine group (66.3%, 179/270) as compared to Anti-Vaccine (45.3%, 24/53) and to Dependent (60.3%, 47/78) groups had a COVID-19 history. Hospitalization history was significantly more common in Pro-Vaccine (11.1%, 30/270) and Dependent groups (16.7%, 13/78) than in Anti-Vaccine group (1.9%, 1/53).Influenza vaccine effectiveness was doubted by 19.7% (79/401), 18% (72/401) participants questioned safety, and 18.7% (75/401) agreed that the vaccine causes disease. The majority of both Dependent (54.2%, 13/24) and Pro-Vaccine (56.2%, 167/297) groups believed they received sufficient information about the vaccine, while only 25% (20/80) of the Anti-Vaccine group has similar impressions.

Conclusions: This analysis reveals a notable disinclination towards vaccination among some of the elderly, reflecting their deep and ingrained hesitancy. These findings emphasize the need for customized approaches to improve vaccine acceptance in this vulnerable group. Such strategies should consider the various motivations and influences shaping elderly perspectives, from individual health experiences to wider social and cultural factors.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11780388PMC
http://dx.doi.org/10.1016/j.jvacx.2024.100569DOI Listing

Publication Analysis

Top Keywords

covid-19 influenza
16
vaccine effectiveness
8
anti-vaccine group
8
covid-19
7
vaccine
7
influenza
6
participants
6
group
5
evaluation vaccine
4
vaccine perceptions
4

Similar Publications

Influenza vaccine effectiveness against influenza-associated hospitalizations in children, Hong Kong, November 2023 to June 2024.

Vaccine X

October 2024

WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region.

We conducted a test negative study from November 2023 to June 2024, enrolling 4,367 children hospitalized with acute respiratory illness in Hong Kong. Among the children who tested negative for influenza virus and SARS-CoV-2, 56.8 % had received influenza vaccination.

View Article and Find Full Text PDF

Evaluation of vaccine perceptions in Israel's Elderly: A Comparative study of COVID-19 and influenza vaccination attitudes.

Vaccine X

October 2024

Clinical Microbiology Laboratory, Tzafon Medical Center, Poriya, Israel, affiliated with Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel.

Purpose: This study aimed to evaluate the attitudes of Israeli elderly population towards COVID-19 and influenza vaccines, and to assess factors contributing to these attitudes.

Methods: Four-hundred and one participants exhibiting symptoms consistent with COVID-19 or influenza were enrolled and filled out a questionnaire. A second questionnaire was filled out for hospitalized patients at discharge.

View Article and Find Full Text PDF

First insight into eosinophils as a biomarker for the early distinction of COVID-19 from influenza A in outpatients.

Exp Ther Med

March 2025

Department of Infectious Diseases, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, P.R. China.

Coronavirus disease 2019 (COVID-19) and influenza A outbreaks have spread rapidly in China. It is difficult to accurately differentiate these two different respiratory tract infections on the basis of their similar early-stage symptoms and lymphocytopenia. In the present study, the age, sex and white blood cell, neutrophil, lymphocyte, monocyte and eosinophil counts, as well as the neutrophil-to-lymphocyte ratio (NLR) of 201 outpatients with confirmed COVID-19 and 246 outpatients with influenza A were investigated and compared.

View Article and Find Full Text PDF

Invasive aspergillosis in critically ill patients with diabetes mellitus: a systematic review and meta-analysis.

BMC Infect Dis

January 2025

State Key Lab of Respiratory Diseases, Guangzhou Institute of Respiratory Health, Department of Critical Care Medicine, The First Affiliated Hospital of Guangzhou Medical University, 151 Yanjiang Street West, Guangzhou, 510120, Guangdong, China.

Background: In the intensive care unit (ICU), invasive aspergillosis (IA) has a poor prognosis. Some studies report a positive association between diabetes mellitus (DM) and IA in critically ill patients, but the relationship between DM and IA in the ICU remains controversial. We aimed to clarify the relationship between DM and IA among patients in the ICU in a systematic review and meta-analysis.

View Article and Find Full Text PDF

Tunable control of Cas12 activity promotes universal and fast one-pot nucleic acid detection.

Nat Commun

January 2025

CAS Key Laboratory of Urban Pollutant Conversion, Department of Environmental Science and Engineering, University of Science and Technology of China, 230026, Hefei, China.

The CRISPR-based detection methods have been widely applied, yet they remain limited by the non-universal nature of one-pot diagnostic approaches. Here, we report a universal one-pot fluorescent method for the detection of epidemic pathogens, delivering results within 15-20 min. This method uses heparin sodium to precisely tunes the cis-cleavage capability of Cas12 via interference with the Cas12a-crRNA binding process, thereby generating significant fluorescence due to the accumulation of isothermal amplification products.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!